For each valorisation project a flyer is created that explains the opportunity presented by the novel invention that is available for commercial (co-)development. Our portfolio currently contains the following licensing opportunities:
Innovative Anti-Cancer Therapy
A patent application for diagnostic and therapeutic cancer applications has been filed and Maastricht University is searching for a research and development partnership.
Predictive Biomarker for Pediatric Liver Disease
Patent pending (PCT/EP2015/073683)
Treating Cognitive Impairment with Roflumilast
Two patent applications (roflumilast in monotherapy and roflumilast in combination therapy with acetylcholinesterase inhibitors) have been filed by Maastricht University and are available for licensing. Maastricht University is searching for partner(s) to complete development and commercialization
LY75 Methylation for Predicting Disease Outcome in Melanoma
The patent application has been filed by Maastricht University and is available for licensing. Maastricht University is searching for partner(s) to complete development and commercialization.
Multiwell In Vitro In Vivo
This multiwell High Throughput Screening (HTS) approach embodies a practical strategy which features some unique selling points. Download pdf
If you are interested in any of these opportunities, please get in touch with the contact person referred to on the specific flyer, or the Brightlands Maastricht Health Campus.